Cellebrite Shares Drop After 1Q Revenue Miss

Dow Jones
2025/05/14
 

By Chris Wack

 

Cellebrite shares were down 7% to $18.71 after the company reported first-quarter revenue that was below analysts' expectations.

The technology company said it had quarterly revenue of $107.5 million, compared to $89.6 million in the same quarter last year. Analysts polled by FactSet were looking for revenue of $109.3 million.

The company swung to a profit this quarter, seeing earnings of $17.4 million, or 7 cents a share, compared with a loss of $71.4 million, or 36 cents a share, last year. Analysts were expecting earnings of $11.6 million, or 5 cents a share.

Adjusted earnings were 10 cents a share, compared with the 7 cents a share analysts had forecast.

Cellebrite said its subscription revenue was $95.8 million in the first quarter, up 21% year-over-year, and annual recurring revenue was $408 million, up 23% year-over-year.

The company is expecting quarterly revenue of $110 million to $116 million, compared with the $115.3 million analysts are looking for. For 2025, Cellebrite is looking for revenue of $470 million to $485 million, while analysts are forecasting 2025 revenue of $484.2 million.

Cellebrite said its outlook for the second quarter reflects its expectation that the current U.S. Federal spending environment will persist into the second quarter. Its 2025 revenue target now reflects the timing of net new business in the second half of its year, combined with lower anticipated one-time professional services revenue from the U.S. Federal vertical.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

May 14, 2025 10:41 ET (14:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10